Full-Time

Senior Manager Trade Compliance

Intuitive Surgical

Intuitive Surgical

10,001+ employees

Manufactures robotic surgical systems and services

No salary listed

Bengaluru, Karnataka, India

In Person

Category
Legal & Compliance (1)
Required Skills
SAP Products
Word/Pages/Docs
Risk Management
Data Governance
Excel/Numbers/Sheets

Get referred to Intuitive Surgical

See people who can refer or advise you

Requirements
  • Strong technical knowledge of global Trade Compliance principles (customs valuation, incoterms, license and permits, country of origin, HTS classifications, duty optimization / Free Trade Agreements, export controls and sanctions etc.)
  • Strong knowledge of APAC customs regulations schemes and requirements. (AEO, IPR)
  • Experience with leading, executing, and maintaining trade operations and trade programs.
  • Demonstrate ability to transform strategic vision into innovative solutions from existing resources.
  • Must possess strong analytical and change management skills, critical thinking, and problem solving with experience in risk management processes and gap analysis.
  • Must be able to maintain a high level of confidentiality.
  • Excellent verbal and written communication skills, and present effectively and persuasively at all levels.
  • Bring extensive industry knowledge and demonstrated ability to influence at the Intuitive leadership site level.
  • Proficient in the use of Microsoft Outlook, Word, Excel, and PowerPoint.
  • Strong organization skills, able to multi-task, and can manage time to meet frequently changing deadlines in a fast-paced environment.
  • Strong cross-functional collaboration skills and ability to influence others through demonstrated expertise. Ability to manage multiple cross-organizational projects.
  • Must be a team player, work effectively both independently and collaboratively.
  • Strong working experience with databases, enterprise resource planning (ERP), global trade automation solutions, and the Automated Commercial Environment (ACE) functionality.
  • Experience in implementing and maintaining the C-TPAT, AEO programs and duty drawback.
  • Ability to handle multiple competing priorities in a fast-paced environment while working with multiple stakeholders to develop and scale the programs.
  • Detail oriented and highly organized with ability to multi-task and minimal guidance.
Responsibilities
  • Develop, implement, and manage the relevant trade compliance policies and procedures manuals and standard work documents necessary to successfully manage import and export operations across the region.
  • Supervise import/ export transactions, processes and documentation requirements to facilitate the smooth flow of goods across borders while minimizing delays and costs.
  • Oversee daily import / export shipment clearance operations. Lead broker reviews and monitoring to enhance broker performance and cycle times.
  • Manage compliance with preferential-and non-preferential trade, duty suspension, drawback programs and economical customs procedures where applicable.
  • Ensure Regional data integrity related to tariff classification, country of origin, and regulatory information declared to Customs and other Government Agencies.
  • Develop and implement audit programs to ensure the accuracy in the shipping document and customs declaration.
  • Oversee import and export recordkeeping practices to ensure compliance with Corporate Policy and regulations of all government agencies.
  • Supervise pre- and post-entry audits related to customs declaration, forwarder/ brokers, other logistics service providers and suppliers. Follow up with appropriate corrective action and make corrections when non-compliance is identified.
  • Monitor forwarders and customs brokers and evaluate adherence to Intuitive Brokerage SOP and metrics. Report findings to Corporate Logistics Compliance and follow up with documented corrective action related to monthly brokerage metrics reports.
  • Develop and conduct internal risk assessments. Follow-up with Compliance Improvement Plans.
  • Monitor and report on trade compliance effectiveness, identify gaps, advise on local risk and manage mitigation of these risks.
  • Develop and implement cross-functional training program on import/ export requirements.
  • Audit and maintain data governance in SAP and global product database and applicable trade compliance records in accordance with regulatory requirements.
  • Provide accurate trade data element including product classification, ECCN, country of origin, license determination to internal business units and outside service providers to ensure compliance with Customs regulations and other trade requirements.
  • Serve as a subject matter expert on customs compliance matters, providing guidance and support to internal stakeholders on complex issues and transactions.
  • Participate as core team member on new product development, new market launch, new product launch ensuring that all trade compliance requirements are met.
  • Communicate risks, proposals, regulatory updates and strategies to internal and external stakeholders.
  • Interact with IT and Center of Excellence (COE) to streamline and improve import/ export data for compliance; communicate requirements to IT and assist with testing and solutions implementation.
  • Conduct and report findings of internal risk assessments. Follow-up with Compliance Improvement Plans.
  • Provide training to other functional groups on trade programs and import and export requirements.
  • Assist in global and/or regional compliance projects/programs.
  • Provide assistance to company sites, suppliers, and customers in the continuous improvement of their compliance functions.
  • Perform other duties, tasks, special projects as assigned.
Desired Qualifications
  • Understanding and experience with the importation and exportation of medical devices.
  • Experience in implementing and maintaining Global Trade Management Software.
  • Experience in SAP S4/ HANA, Agile, and related transactional and outputs are preferred.
  • Previous customs compliance experience is preferred.
  • Six-Sigma experience preferred.

Intuitive Surgical designs, manufactures, and sells robotic surgical systems and provides related services and accessories for minimally invasive surgery. The core product helps surgeons perform operations with enhanced precision by guiding robotic arms controlled from a console, allowing procedures to be done through small incisions. Instruments and consumables are used with the systems and are supported by service contracts, creating a recurring revenue stream. Compared to competitors, Intuitive has a large installed base and focuses specifically on robotic-assisted surgery, combining devices, disposable instruments, and ongoing services to support hospitals and surgical centers. Its goal is to improve patient outcomes by enabling safer, less invasive procedures while expanding the use and capabilities of robotic surgery for more procedures and providers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Sunnyvale, California

Founded

1995

Get referred to Intuitive Surgical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue rose 19% to $2.89 billion, beating estimates on July 16.
  • Penang lease adds 316,000 square feet and 1,200 jobs, supporting Asia-Pacific growth.
  • Management kept 2026 da Vinci growth at 13.5%-15.5% and raised gross-margin guidance.

What critics are saying

  • FDA recall tracker listed multiple 2026 da Vinci Class II recalls, signaling quality-control strain.
  • Medtronic Hugo gained U.S. urology clearance in December 2025, tightening robotic-surgery competition.
  • 2027 extended instrument-use changes risk recurring revenue erosion if hospitals delay upgrades.

What makes Intuitive Surgical unique

  • Da Vinci installed base neared 13,000 systems worldwide, locking in switching costs.
  • Da Vinci 5 launched broadly in the U.S. in 2025, boosting utilization.
  • Ion procedures grew 36% in Q2 2026, extending Intuitive beyond soft-tissue robotics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Aug 19th, 2026
Abbott beats Q2 estimates with 13% sales growth as diagnostics surge 42%, while Intuitive Surgical posts 19% revenue rise

Abbott Laboratories reported strong fiscal Q2 2026 results, with sales rising 13% on a reported basis and 4.8% on a comparable basis, beating estimates and prompting the company to raise its annual profit forecast. The diagnostics segment was particularly strong, growing 42% to $3.09 billion, driven by its cancer diagnostics business following the Exact Sciences acquisition. Intuitive Surgical also exceeded expectations in Q2 2026, with revenue growing 19% to $2.89 billion and adjusted EPS of $2.80, beating forecasts by $0.30. The company placed 468 da Vinci units during the quarter, an 18% year-over-year increase, whilst maintaining a non-GAAP gross margin of 70.0%. The companies present contrasting investment cases: Abbott offers diversified healthcare portfolio resilience, whilst Intuitive Surgical relies on its robotic surgery ecosystem with recurring revenue comprising approximately 85% of total sales.

PR Newswire
Aug 17th, 2026
Intuitive leases 316,000-sq-ft facility in Penang to manufacture surgical instruments, create 1,200 jobs by 2032

Intuitive, the global leader in minimally invasive care and pioneer of robotic-assisted surgery, has signed a lease agreement with Penang Development Corporation for a new manufacturing facility in Malaysia. The 316,000-square-foot site in Bandar Cassia Technology Park will produce surgical instruments and electromechanical devices for Intuitive's da Vinci surgical system. The facility is expected to begin operations in 2028 and create 1,200 highly skilled jobs by 2032. The investment reflects Intuitive's commitment to Asia Pacific, where its da Vinci systems have treated more than 2.5 million patients across 13 markets over two decades. The expansion aims to support growing demand for robotic-assisted surgery across the region and strengthen Penang's position as a MedTech manufacturing hub in Southeast Asia.

Yahoo Finance
Aug 16th, 2026
Oppenheimer upgrades Intuitive Surgical to 'Outperform' with $500 price target

Oppenheimer upgraded Intuitive Surgical from "Perform" to "Outperform" with a $500 price target, implying a 24.6% upside. The analysts expect the medtech company to maintain its leading position in robotic surgery despite increasing competition. Intuitive reported strong Q2 results, with revenue rising 18.5% year-over-year to $2.89 billion, surpassing analyst expectations. Non-GAAP earnings per share climbed 27.9% to $2.80, beating the $2.50 estimate. The company placed 468 da Vinci surgical systems and 55 Ion endoluminal systems during the quarter. Combined da Vinci and Ion procedures rose approximately 16% globally. Wall Street maintains a "Strong Buy" consensus rating on the stock, with 22 of 31 analysts recommending a strong buy. The consensus price target of $480.93 represents a 19.85% upside.

Yahoo Finance
Aug 12th, 2026
Intuitive Surgical's valuation barely budges despite two years of growth forecasts

Intuitive Surgical trades at $401.23, down 32% from its 52-week high and 15% over twelve months. The stock currently trades at 37.7 times trailing adjusted earnings. Analysts forecast earnings of $12.08 per share by 2027, bringing the multiple down to 33 times — only 13% lower despite two years of growth. Consensus projects 7% annual earnings growth and 9.7% revenue growth, suggesting margin compression ahead. Management raised its 2026 gross profit margin guidance to 68-69%. However, the company plans to extend instrument use limits starting in the first half of 2027 to lower procedure costs and boost adoption. Intuitive has not finalised pricing for this programme, creating uncertainty around 2027 estimates. The company will quantify the impact on its next earnings call.

Yahoo Finance
Aug 8th, 2026
Medtronic and Intuitive Surgical lag market amid sector weakness

Medtronic and Intuitive Surgical, two medical device leaders, have underperformed this year due to sector weakness and company-specific challenges. However, both show potential for recovery. Medtronic's fourth-quarter revenue rose 9.9% to $9.8 billion, though adjusted earnings per share fell 4.3% to $1.55 due to higher costs, including tariffs. The company posted its highest annual revenue growth in a decade, driven partly by its Pulse Field Ablation franchise. Medtronic recently received FDA clearance for its Hugo robotic-assisted surgery system for urologic procedures, positioning it to compete in the underpenetrated robotic surgery market. The company plans to spin off its lower-margin diabetes care division, which should improve margins. With a 3.4% forward dividend yield and 49 consecutive years of payout increases, Medtronic appeals to income-focused investors.